Maccura Biotechnology Co.Ltd (SHE:300463)
China · Delayed Price · Currency is CNY 9.35
+0.10 (1.08%)
Sep 1, 2026, 3:04 PM CST
SHE:300463 Market Cap
SHE:300463 has a market cap or net worth of 5.59 billion as of August 31, 2026. Its market cap has decreased by -25.04% in one year.
Market Cap
5.59B
Enterprise Value
5.75B
Revenue
2.13B
Ranking
n/a
PE Ratio
n/a
Stock Price
9.35
ChartMarket Cap Chart
Since May 28, 2015, SHE:300463's market cap has decreased from 7.49B to 5.59B, a decrease of -25.31%. That is a compound annual growth rate of -2.56%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2026 | 5.59B | -17.34% |
| Dec 31, 2025 | 6.77B | -15.53% |
| Dec 31, 2024 | 8.01B | -13.22% |
| Dec 29, 2023 | 9.23B | -12.89% |
| Dec 30, 2022 | 10.60B | -34.77% |
| Dec 31, 2021 | 16.24B | -37.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Dian Diagnostics Group | 11.40B |
| Beijing Strong Biotechnologies,Inc. | 6.86B |
| Amoy Diagnostics | 6.85B |
| Shanghai Runda Medical Technology | 5.93B |
| Cowealth Medical China | 4.93B |
| Shanghai Labway Clinical Laboratory | 4.45B |
| Guangdong Hybribio Biotech | 3.80B |
| Thalys Medical Technology Group | 3.66B |